HOLOGIC 20/29 REGSHOLOGIC 20/29 REGSHOLOGIC 20/29 REGS

HOLOGIC 20/29 REGS

No trades
See on Supercharts

USU38284AF9 analysis



Key facts


Issue date
Sep 28, 2020
Maturity date
Feb 15, 2029
Outstanding amount
‪950.00 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
3.25% (Fixed)
Yield to maturity
5.66%
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.